Myeloma-derived macrophage inhibitory factor regulates bone marrow stromal cell-derived IL-6 via c-MYC
Abstract Multiple myeloma (MM) remains an incurable malignancy despite the recent advancements in its treatment. The protective effects of the niche in which it develops has been well documented; however, little has been done to investigate the MM cell’s ability to ‘re-program’ cells within its envi...
Main Authors: | Rachel E. Piddock, Christopher R. Marlein, Amina Abdul-Aziz, Manar S. Shafat, Martin J. Auger, Kristian M. Bowles, Stuart A. Rushworth |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13045-018-0614-4 |
Similar Items
-
cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis
by: Hany I. Sakr, et al.
Published: (2017-10-01) -
WT1 Enhances Proliferation and Impedes Apoptosis in KRAS Mutant NSCLC via Targeting cMyc
by: Chen Wu, et al.
Published: (2015-01-01) -
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
by: Jasmine George, et al.
Published: (2021-11-01) -
Elevated Nuclear PHGDH Synergistically Functions with cMyc to Reshape the Immune Microenvironment of Liver Cancer
by: Hongwen Zhu, et al.
Published: (2023-06-01) -
Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis
by: Mingming Zhang, et al.
Published: (2019-03-01)